KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Free Cash Flow (2017 - 2025)

Cardlytics (CDLX) has disclosed Free Cash Flow for 9 consecutive years, with $12.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow fell 14.62% year-over-year to $12.7 million, compared with a TTM value of $8.8 million through Dec 2025, up 184.83%, and an annual FY2025 reading of $8.8 million, up 184.83% over the prior year.
  • Free Cash Flow was $12.7 million for Q4 2025 at Cardlytics, up from $1.8 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $14.8 million in Q4 2024 and bottomed at -$22.7 million in Q3 2022.
  • Average Free Cash Flow over 5 years is -$5.5 million, with a median of -$7.0 million recorded in 2022.
  • Peak annual rise in Free Cash Flow hit 268.81% in 2024, while the deepest fall reached 1030.15% in 2024.
  • Year by year, Free Cash Flow stood at -$1.5 million in 2021, then crashed by 236.1% to -$5.1 million in 2022, then plummeted by 72.3% to -$8.8 million in 2023, then surged by 268.81% to $14.8 million in 2024, then dropped by 14.62% to $12.7 million in 2025.
  • Business Quant data shows Free Cash Flow for CDLX at $12.7 million in Q4 2025, $1.8 million in Q3 2025, and $1.2 million in Q2 2025.